Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$56.72 USD
+0.53 (0.94%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $56.60 -0.12 (-0.21%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Exact Sciences Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
EXAS 56.72 +0.53(0.94%)
Will EXAS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for EXAS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EXAS
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy?
EXAS: What are Zacks experts saying now?
Zacks Private Portfolio Services
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute
Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
Other News for EXAS
EXAS rises 0.94% on October 3, leaving the technical picture intact
Stochastic Reached Overbought appears for EXAS after 0.43% move
EXAS: Barclays Raises Price Target to $65.00 Amid Overweight Rating | EXAS Stock News
Is EXAS likely to continue higher? MACD Bullish Signal Line Cross shows up after advancing 3.14%
Exact Sciences price target raised to $65 from $55 at Barclays